Camsirubicin

DB13103InvestigationalSmall molecule

GPX-150 has been used in trials studying the treatment of Soft Tissue Sarcoma and Advanced Solid Tumors - Phase 1 Population.

Chemical structure of Camsirubicin
Formula / weight
C27H30N2O10 · 542.541 g/mol (avg)
Also known as
5-imino-13-deoxydoxorubicin
Code names
GPX-150

Resolves to

Compound
UNII7W3RB6E22WCAS236095-29-7PubChem10392558
Structure
InChIKeyUNNWAMSRSUVXCZ-PNISCQLKSA-NSMILESCOC1=C2C(=N)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(=O)CO)C(O)=C3C(=O)C2=CC=C1
Targets
P11388TOP2A

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Camsirubicin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In